Presenting our work on computational approaches for human immunogenetic diversity at the EMBO Workshop on GCs and immune niches. Thank you Ziv Shulman Lab Weizmann Institute for hosting. #Immunology #bioinformatics Frankfurt Cancer Institute

Single-Cell Advances in Functional Immune Monitoring for Developing Immune Therapies and Uncovering Disease Pathogenesis genengnews.com/resources/eboo… via Genetic Engineering & Biotechnology News

#Immunotherapy-Related Myocarditis Linked to T Cells Targeting Cardiac-Specific Antigen. Learn more: ow.ly/XsKx50LGVho

People with untreatable cancers have had their immune system redesigned to attack their own tumours. bbc.com/news/health-63… #ImmuneSystem #Transforming #Tcells #Cancer

The next talk in the iR+ series will be held today and we are pleased to welcome Katharina Imkeller, Frankfurt Cancer Institute, and Jarrod Shilts, Wellcome Sanger Institute. For more information, visit: ireceptor-plus.com/news-and-event… #Bcells #Tcell #Receptors #HLAs #KIRs #Human #Immune #Cells

Katharina Imkeller from the Frankfurt Cancer Institute opened the first session of our seminar today with her presentation on human immunogenetic diversity in single-cell transcriptomic data. ireceptor-plus.com/news-and-event… #singlecell #transcriptomic #human #leukocyte #antigens #hla

Jarrod Shilts from the Wellcome Sanger Institute, speaks on a systematic view of the receptor wiring network that connects human immune cells, at the second session of the iReceptor Plus Seminar Series. ireceptor-plus.com/news-and-event… #immunecells #interaction

Memory B and T cells responses differ when induced by SARS-CoV-2 infections or booster vaccinations news-medical.net/news/20221127/… #SARSCoV2 #Coronavirus #Disease #COVID #BCell #TCell J Immunol Keio Global

The final meeting of the EU-funded iReceptor Plus has just opened in the Paris. The project coordinator, Prof. Gur Yaari of the Bar-Ilan University opened the meeting, which summarizes the four years of hard work invested in the project. ireceptor-plus.com #EU #H2020

Raymond Slaughter from Agora partners presents at the partners meeting plans to commercialize the iReceptor Plus Platform, an excellent tool which expected to lead to development of new vaccines, monoclonal antibodies for cancer and autoimmune treatment. ireceptor-plus.com/the-platform/o…

Prof. Felix Breden, iReceptor Plus’s scientific manager, presents the impressive achievements the project has achieved over the last four years at the final consortium meeting hosted by the Sorbonne University. ireceptor-plus.com #iReceptorPlus #EU #Research #Innovation

A new study in mice by researchers at the Garvan Institute of Medical Research demonstrates that gene variants associated with leukemia can produce “rogue” immune cells that drive autoimmune diseases. Learn more: ow.ly/MAAs50LQ0s3

The international iReceptor Plus Project revealed a new version of the iReceptor Plus Platform that can be used to develop new #vaccines, monoclonal antibodies for #cancer and #autoimmune treatment. ireceptor-plus.com/news-and-event… #EU #Canada #H2020 #Immunology #Research #Bcells #Tcells

Season's Greetings and Best Wishes for 2023

iReceptor Gateway is pleased to announce the addition of a new #T1D focused repository in the airr_community #AIRRDataCommons, collaborating with the(sugar)science, Aaron Michels CU Anschutz Medical Campus, Todd M. Brusko and others. Hoping to grow the #T1D data community like we did #COVID19. 🧵1/N

Immune Profiling: Standardizing and Accessing Immunogenetic Data genengnews.com/resources/biot… via Genetic Engineering & Biotechnology News

Natural immunity to COVID-19 could be the key to curing cancer, according to a team of Australian researchers. 9news.com.au/national/cance… #Cancer #Tcells #Bloodcells #COVID19

T cells can activate themselves to fight tumors: « We’ve found a way that T cells are able to live outside of their normal homes and survive in the foreign environment of a tumor. » UC San Diego #tcell #cancer #immunology today.ucsd.edu/story/t-cells-…

In a paper in The Lancet Neurology, researchers describe how immunotherapy might be used to correct an immune system that has itself gone haywire econ.st/3r2S9I4